Literature DB >> 20040878

Under-treatment of cancer pain.

Alysa Fairchild1.   

Abstract

PURPOSE OF REVIEW: Cancer pain remains inadequately treated, despite internationally accepted management guidelines and a myriad of treatment options. Risk factors for undertreatment are reviewed, along with possible explanations. Recent studies documenting the scope of the problem as well as investigating solutions are discussed with clinical-practice recommendations outlined. RECENT
FINDINGS: Women over 65 years of age representative of a cultural minority, with earlier stage disease, cared for at home, and with high-school education or less are at highest risk of having uncontrolled cancer pain. Optimal treatment is impeded by patients' maladaptive beliefs, nonadherence, underreporting or miscommunication with caregivers; from a healthcare provider perspective, it may be due to inadequate assessment, documentation, knowledge, and communication. Emerging data support the vital influence of lay caregivers on appropriate pain management. Although home-education programs may decrease pain and improve quality of life, there are also less intensive approaches deliverable by individuals to holistically address pain.
SUMMARY: Prospective study of barriers to both delivery and receipt of adequate pain management is needed, as the majority of published literature is based on survey studies. Treatment must be individualized based on clinical circumstances and patient wishes, with the goal of maximizing function and quality of life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20040878     DOI: 10.1097/SPC.0b013e328336289c

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  30 in total

1.  Predictors of cancer-related pain improvement over time.

Authors:  Hsiao-Lan Wang; Kurt Kroenke; Jingwei Wu; Wanzhu Tu; Dale Theobald; Susan M Rawl
Journal:  Psychosom Med       Date:  2012-06-28       Impact factor: 4.312

2.  [Neuropathic and tumour-induced headache: Therapeutic options].

Authors:  A Wagner; J A Blunk; J Benrath
Journal:  HNO       Date:  2011-07       Impact factor: 1.284

Review 3.  Neoclerodanes as atypical opioid receptor ligands.

Authors:  Thomas E Prisinzano
Journal:  J Med Chem       Date:  2013-04-18       Impact factor: 7.446

4.  Comparative responsiveness of pain measures in cancer patients.

Authors:  Kurt Kroenke; Dale Theobald; Jingwei Wu; Wanzhu Tu; Erin E Krebs
Journal:  J Pain       Date:  2012-07-15       Impact factor: 5.820

5.  Pain medication management processes used by oncology outpatients and family caregivers part I: health systems contexts.

Authors:  Karen L Schumacher; Vicki L Plano Clark; Claudia M West; Marylin J Dodd; Michael W Rabow; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2014-04-04       Impact factor: 3.612

6.  Patient-reported quality of care and pain severity in cancer.

Authors:  Kathryn A Martinez; Claire F Snyder; Jennifer L Malin; Sydney M Dy
Journal:  Palliat Support Care       Date:  2014-06-26

Review 7.  An overview of the patterns of prescription opioid use, costs and related harms in Australia.

Authors:  Bianca Blanch; Sallie-Anne Pearson; Paul S Haber
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

8.  Pain assessment: the roles of physician certainty and curiosity.

Authors:  Cleveland G Shields; Michelle A Finley; Cezanne M Elias; Casey J Coker; Jennifer J Griggs; Kevin Fiscella; Ronald M Epstein
Journal:  Health Commun       Date:  2013-01-28

9.  Quality of life in cancer patients with pain in beijing.

Authors:  Ping Yang; Li-Qiu Sun; Dong Pang; Yue Ding
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

10.  Is race/ethnicity related to the presence or severity of pain in colorectal and lung cancer?

Authors:  Kathryn A Martinez; Claire F Snyder; Jennifer L Malin; Sydney M Dy
Journal:  J Pain Symptom Manage       Date:  2014-04-18       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.